Your browser doesn't support javascript.
loading
Mesial temporal resection following long-term ambulatory intracranial EEG monitoring with a direct brain-responsive neurostimulation system.
Hirsch, Lawrence J; Mirro, Emily A; Salanova, Vicenta; Witt, Thomas C; Drees, Cornelia N; Brown, Mesha-Gay; Lee, Ricky W; Sadler, Toni L; Felton, Elizabeth A; Rutecki, Paul; Shin, Hae Won; Hadar, Eldad; Hegde, Manu; Rao, Vikram R; Mnatsakanyan, Lilit; Madhavan, Deepak S; Zakaria, Tarek J; Liu, Anli A; Heck, Christianne N; Greenwood, Janet E; Bigelow, Jeffrey K; Nair, Dileep R; Alexopoulos, Andreas V; Mackow, Michael; Edwards, Jonathan C; Sotudeh, Nadia; Kuzniecky, Ruben I; Gwinn, Ryder P; Doherty, Michael J; Geller, Eric B; Morrell, Martha J.
Afiliação
  • Hirsch LJ; Yale University School of Medicine, New Haven, CT, USA.
  • Mirro EA; NeuroPace, Inc., Mountain View, CA, USA.
  • Salanova V; Indiana University School of Medicine, Indianapolis, IN, USA.
  • Witt TC; Indiana University School of Medicine, Indianapolis, IN, USA.
  • Drees CN; University of Colorado School of Medicine, Aurora, CO, USA.
  • Brown MG; University of Colorado School of Medicine, Aurora, CO, USA.
  • Lee RW; Via Christi Epilepsy Center, Wichita, KS, USA.
  • Sadler TL; Via Christi Epilepsy Center, Wichita, KS, USA.
  • Felton EA; University of Wisconsin Hospital & Clinics, Madison, WI, USA.
  • Rutecki P; University of Wisconsin Hospital & Clinics, Madison, WI, USA.
  • Shin HW; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Hadar E; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
  • Hegde M; Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
  • Rao VR; Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.
  • Mnatsakanyan L; University of California Irvine Medical Center, Orange, CA, USA.
  • Madhavan DS; University of Nebraska Medical Center, Omaha, NE, USA.
  • Zakaria TJ; Memorial Healthcare System, Hollywood, FL, USA.
  • Liu AA; New York University School of Medicine, New York, NY, USA.
  • Heck CN; Keck School of Medicine at University of Southern California, Los Angeles, CA, USA.
  • Greenwood JE; Keck School of Medicine at University of Southern California, Los Angeles, CA, USA.
  • Bigelow JK; Intermountain Medical Center, Murray, UT, USA.
  • Nair DR; Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Alexopoulos AV; Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Mackow M; Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Edwards JC; Medical University of South Carolina, Charleston, SC, USA.
  • Sotudeh N; Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA.
  • Kuzniecky RI; Zucker School of Medicine at Hofstra/Northwell, New York, NY, USA.
  • Gwinn RP; Swedish Neuroscience Institute, Seattle, WA, USA.
  • Doherty MJ; Swedish Neuroscience Institute, Seattle, WA, USA.
  • Geller EB; Saint Barnabas Medical Center, Livingston, NJ, USA.
  • Morrell MJ; NeuroPace, Inc., Mountain View, CA, USA.
Epilepsia ; 61(3): 408-420, 2020 03.
Article em En | MEDLINE | ID: mdl-32072621
ABSTRACT

OBJECTIVE:

To describe seizure outcomes in patients with medically refractory epilepsy who had evidence of bilateral mesial temporal lobe (MTL) seizure onsets and underwent MTL resection based on chronic ambulatory intracranial EEG (ICEEG) data from a direct brain-responsive neurostimulator (RNS) system.

METHODS:

We retrospectively identified all patients at 17 epilepsy centers with MTL epilepsy who were treated with the RNS System using bilateral MTL leads, and in whom an MTL resection was subsequently performed. Presumed lateralization based on routine presurgical approaches was compared to lateralization determined by RNS System chronic ambulatory ICEEG recordings. The primary outcome was frequency of disabling seizures at last 3-month follow-up after MTL resection compared to seizure frequency 3 months before MTL resection.

RESULTS:

We identified 157 patients treated with the RNS System with bilateral MTL leads due to presumed bitemporal epilepsy. Twenty-five patients (16%) subsequently had an MTL resection informed by chronic ambulatory ICEEG (mean = 42 months ICEEG); follow-up was available for 24 patients. After MTL resection, the median reduction in disabling seizures at last follow-up was 100% (mean 94%; range 50%-100%). Nine patients (38%) had exclusively unilateral electrographic seizures recorded by chronic ambulatory ICEEG and all were seizure-free at last follow-up after MTL resection; eight of nine continued RNS System treatment. Fifteen patients (62%) had bilateral MTL electrographic seizures, had an MTL resection on the more active side, continued RNS System treatment, and achieved a median clinical seizure reduction of 100% (mean 90%; range 50%-100%) at last follow-up, with eight of fifteen seizure-free. For those with more than 1 year of follow-up (N = 21), 15 patients (71%) were seizure-free during the most recent year, including all eight patients with unilateral onsets and 7 of 13 patients (54%) with bilateral onsets.

SIGNIFICANCE:

Chronic ambulatory ICEEG data provide information about lateralization of MTL seizures and can identify additional patients who may benefit from MTL resection.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lobo Temporal / Lobectomia Temporal Anterior / Epilepsia do Lobo Temporal / Epilepsia Resistente a Medicamentos Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lobo Temporal / Lobectomia Temporal Anterior / Epilepsia do Lobo Temporal / Epilepsia Resistente a Medicamentos Tipo de estudo: Observational_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article